🇺🇸 LIVTENCITY in United States

FDA authorised LIVTENCITY on 23 November 2021

Marketing authorisations

FDA — authorised 23 November 2021

  • Application: NDA215596
  • Marketing authorisation holder: TAKEDA PHARMS USA
  • Status: supplemented

FDA

  • Status: approved

LIVTENCITY in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is LIVTENCITY approved in United States?

Yes. FDA authorised it on 23 November 2021; FDA has authorised it.

Who is the marketing authorisation holder for LIVTENCITY in United States?

TAKEDA PHARMS USA holds the US marketing authorisation.